pyrroles has been researched along with Herpes Zoster in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.06) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 23 (69.70) | 24.3611 |
| 2020's | 8 (24.24) | 2.80 |
| Authors | Studies |
|---|---|
| Choy, EH; Dews, SA; Galloway, J; Raine, T; Rivett, L; Roberts, J | 1 |
| Bilgin, E; Duran, E; Ertenli, İ; Kalyoncu, U; Kiraz, S; Ünaldı, E | 1 |
| D'Haens, GR; Guo, X; Kulisek, N; Lawendy, N; Modesto, I; Mundayat, R; Ng, SC; Panaccione, R; Panés, J; Sandborn, WJ; Sands, BE; Su, C; Vranic, I | 1 |
| Ahmed, HM; Chan, G; Cohen, BL; Lichtenstein, GR; Modesto, I; Peyrin-Biroulet, L; Salese, L; Su, C; Wang, W | 1 |
| Bonovas, S; Danese, S; Lasa, JS; Olivera, PA; Peyrin-Biroulet, L | 1 |
| Morinobu, A | 1 |
| Chen, DY; Chen, HH; Chen, JP; Chen, YH; Chen, YJ; Chen, YM; Hsieh, TY; Huang, WN; Liao, TL | 1 |
| Cohen, AD; Egeberg, A; Gupta, P; Ito, K; Kaur, M; Lebwohl, M; Mallbris, L; Rottinghaus, ST; Tan, H; Tyring, SK; Valdez, H; Weinberg, JM; Winthrop, KL | 1 |
| Cush, JJ | 1 |
| Biswas, P; Choy, EH; Hodge, JA; Mojcik, CF; Nduaka, CI; Needle, E; Passador, S; Rigby, WF; Soma, K; Winthrop, KL; Wouters, AG | 1 |
| Bananis, E; Chen, C; Curtis, JR; Fan, H; Hirose, T; Lindsey, S; Mendelsohn, AM; Nduaka, CI; Tanaka, Y; Valdez, H; Wang, L; Winthrop, KL; Yamaoka, K | 1 |
| McHugh, J | 1 |
| Deleuran, B; Eggertsen, PP; Frøling, M; Mikkelsen, C; Stern, M; van de Looij, A | 1 |
| Arbeit, R; Kanhoush, R; Noell, C | 1 |
| Colombel, JF | 1 |
| Chan, G; Lawendy, N; Long, MD; Melmed, GY; Nduaka, CI; Pedersen, RD; Su, C; Thorpe, AJ; Vermeire, S; Winthrop, KL | 1 |
| Bernatsky, S; Chen, L; Curtis, JR; Winthrop, K; Xie, F; Yang, S; Yun, H | 1 |
| Caldera, F; Cross, RK; Hayney, MS | 1 |
| Deng, W; Sun, L; Wu, Q; Zhang, Z | 1 |
| Cohen, S; Curtis, JR; DeMasi, R; Kwok, K; Lazariciu, I; Lee, EB; Mojcik, C; Silverfield, J; Soma, K; Strengholt, S; Terry, K; Wang, L; Wollenhaupt, J | 1 |
| Atzeni, F; Bechman, K; Cope, AP; Galli, M; Galloway, JB; Norton, S; Subesinghe, S; Winthrop, KL | 1 |
| Abud-Mendoza, C; Calabrese, LH; Fleischmann, R; Iikuni, N; Lee, SH; Lindsey, SM; Luo, Z; Soma, K; Takiya, L; Tatulych, S | 1 |
| Bradley, JD; Fleischmann, R; Gruben, D; Hall, S; Koncz, T; Krishnaswami, S; Lee, EB; van Vollenhoven, RF; Wallenstein, GV; Wilkinson, B; Zang, C; Zwillich, SH | 1 |
| Chew, R; Kawabata, T; Krishnaswami, S; Mortensen, E; Riese, R; Valdez, H; Winthrop, KL; Yamanaka, H | 1 |
| Asahina, A; Etoh, T; Igarashi, A; Imafuku, S; Nagaoka, M; Ohtsuki, M; Saeki, H; Shibasaki, Y; Tomochika, Y; Toyoizumi, S | 1 |
| Bernatsky, S; Curtis, JR; Winthrop, KL; Xie, F; Yun, H | 1 |
| Sonomoto, K; Tanaka, Y | 1 |
| Yamaoka, K | 2 |
| Charles-Schoeman, C; Cohen, SB; Curtis, JR; DeMasi, R; Geier, J; Kwok, K; Lee, EB; Mariette, X; Nash, P; Riese, R; Tanaka, Y; Thirunavukkarasu, K; Wang, L; Winthrop, KL; Wollenhaupt, J | 1 |
| Chen, L; Coe, J; Curtis, JR; Gal-Levy, R; Higginbotham, P; Nowell, WB; O'Hara, K; Sa'adon, R; Safford, M; Willig, J | 1 |
| Bassetti, D | 2 |
10 review(s) available for pyrroles and Herpes Zoster
| Article | Year |
|---|---|
Herpes zoster and Janus kinase inhibition in rheumatology and gastroenterology patients: managing risk and vaccination.
Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Colitis, Ulcerative; Gastroenterology; Herpes Zoster; Humans; Janus Kinase Inhibitors; Janus Kinases; Pyrroles; Rheumatology; Vaccination | 2022 |
Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.
Topics: Arthritis, Rheumatoid; Azetidines; Herpes Zoster; Heterocyclic Compounds, 3-Ring; Humans; Incidence; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Janus Kinases; Piperidines; Placebos; Psoriasis; Purines; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing; Sulfonamides; Survival Analysis; Treatment Outcome; Triazoles | 2020 |
JAK inhibitors for the treatment of rheumatoid arthritis.
Topics: Adamantane; Antirheumatic Agents; Arthritis, Rheumatoid; Azetidines; Benzofurans; Cardiovascular Diseases; Herpes Zoster; Humans; Janus Kinases; Molecular Targeted Therapy; Neutropenia; Niacinamide; Piperidines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; Pyrroles; Sulfonamides; Venous Thromboembolism | 2020 |
[Inhibition of the Janus kinase-signal transducer and activator of transcription is a new treatment modality of rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azetidines; Herpes Zoster; Humans; Janus Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; Pyrroles; Sulfonamides | 2017 |
Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention.
Topics: Antiviral Agents; Colitis, Ulcerative; Disease Management; Herpes Zoster; Herpesvirus 3, Human; Humans; Janus Kinase Inhibitors; Janus Kinases; Piperidines; Prognosis; Pyrimidines; Pyrroles | 2018 |
Tuberculosis, hepatitis B and herpes zoster in tofacitinib-treated patients with rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Asia, Eastern; Drug Therapy, Combination; Herpes Zoster; Herpesvirus 3, Human; Humans; Mycobacterium tuberculosis; Piperidines; Prevalence; Pyrimidines; Pyrroles; Recurrence; Risk; Tuberculosis; Virus Activation | 2019 |
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Azetidines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Female; Herpes Zoster; Heterocyclic Compounds, 3-Ring; Humans; Incidence; Infections; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Purines; Pyrazoles; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Sulfonamides | 2019 |
Relevance of involvement of tofacitinib in T cell subsets to clinical courses and adverse events in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Herpes Zoster; Humans; Janus Kinases; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; T-Lymphocyte Subsets | 2015 |
Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Herpes Zoster; Humans; Janus Kinases; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles | 2016 |
Relation between disease modifying anti-rheumatic drugs and herpes zoster in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Follow-Up Studies; Herpes Zoster; Humans; Incidence; Janus Kinases; Japan; Molecular Targeted Therapy; Piperidines; Product Surveillance, Postmarketing; Pyrimidines; Pyrroles | 2016 |
8 trial(s) available for pyrroles and Herpes Zoster
| Article | Year |
|---|---|
Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme.
Topics: Colitis, Ulcerative; Herpes Zoster; Humans; Janus Kinase Inhibitors; Opportunistic Infections; Protein Kinase Inhibitors; Pyrroles; Skin Neoplasms; Treatment Outcome | 2023 |
The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial.
Topics: Aged; Antibodies, Viral; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Enzyme-Linked Immunospot Assay; Female; Herpes Zoster; Herpes Zoster Vaccine; Herpesvirus 3, Human; Humans; Immunogenicity, Vaccine; Immunoglobulin G; Male; Methotrexate; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; T-Lymphocytes | 2017 |
Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Colitis, Ulcerative; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Incidence; Male; Middle Aged; Piperidines; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; United States; Young Adult | 2018 |
Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study.
Topics: Administration, Oral; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Herpes Zoster; Humans; Male; Middle Aged; Neoplasms; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Time Factors; Treatment Outcome | 2019 |
Live Zoster Vaccine in Patients With Rheumatoid Arthritis Treated With Tofacitinib With or Without Methotrexate, or Adalimumab With Methotrexate: A Post Hoc Analysis of Data From a Phase IIIb/IV Randomized Study.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Herpes Zoster; Herpes Zoster Vaccine; Humans; Incidence; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; Piperidines; Pyrimidines; Pyrroles | 2020 |
Tofacitinib versus methotrexate in rheumatoid arthritis.
Topics: Administration, Oral; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cholesterol; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Herpes Zoster; Humans; Janus Kinase 3; Male; Methotrexate; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles | 2014 |
Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study.
Topics: Administration, Oral; Adult; Aged; Arthritis, Psoriatic; Double-Blind Method; Female; Herpes Zoster; Humans; Japan; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Treatment Outcome | 2016 |
[Use of distamycin A in the therapy of various viral cutaneous diseases due to VZ].
Topics: Amidines; Anti-Bacterial Agents; Antiviral Agents; Chickenpox; Child, Preschool; Clinical Trials as Topic; Evaluation Studies as Topic; Herpes Zoster; Herpesviridae Infections; Herpesvirus 3, Human; Humans; Oligopeptides; Pyrroles; Skin Diseases, Infectious | 1973 |
15 other study(ies) available for pyrroles and Herpes Zoster
| Article | Year |
|---|---|
Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study.
Topics: Etanercept; Herpes Zoster; Herpesvirus 3, Human; Humans; Neoplasms; Piperidines; Pyrimidines; Pyrroles | 2022 |
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis.
Topics: Adrenal Cortex Hormones; Colitis, Ulcerative; Herpes Zoster; Humans; Protein Kinase Inhibitors; Pyrroles; Remission Induction; Treatment Outcome | 2023 |
Herpes Zoster in rheumatoid arthritis patients receiving tofacitinib, a single center experience from Taiwan.
Topics: Aged; Arthritis, Rheumatoid; Case-Control Studies; Female; Herpes Zoster; Humans; Incidence; Interferon-gamma; Lymphocyte Count; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; T-Lymphocytes; Taiwan | 2020 |
Herpes zoster in psoriasis patients treated with tofacitinib.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Asian People; Biological Products; Etanercept; Female; Herpes Zoster; Hospitalization; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Piperidines; Proportional Hazards Models; Psoriasis; Pyrimidines; Pyrroles; Risk Factors; Young Adult | 2017 |
Editorial: Herpes Zoster: Fear the Infection, Value the Solution.
Topics: Arthritis, Rheumatoid; Fear; Herpes Zoster; Humans; Piperidines; Pyrimidines; Pyrroles; Vaccination | 2017 |
Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Clinical Trials as Topic; Databases, Factual; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Herpes Zoster; Humans; Incidence; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Multivariate Analysis; Piperidines; Proportional Hazards Models; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Risk Factors | 2017 |
Rheumatoid arthritis: Reducing the risk of herpes zoster.
Topics: Arthritis, Rheumatoid; Herpes Zoster; Humans; Piperidines; Pyrimidines; Pyrroles; Vaccination | 2017 |
Herpes zoster as a cause of atypical chronic ulcerations associated with tofacitinib.
Topics: Arthritis, Rheumatoid; Chronic Disease; Female; Herpes Zoster; Humans; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin; Skin Ulcer | 2018 |
Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids.
Topics: Aged; Arthritis, Rheumatoid; Databases, Factual; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Herpes Zoster; Humans; Incidence; Janus Kinase Inhibitors; Male; Medicare; Methotrexate; Middle Aged; Multivariate Analysis; Piperidines; Pyrimidines; Pyrroles; Risk Assessment; Time Factors; United States | 2019 |
Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.
Topics: Herpes Zoster; Herpesvirus 3, Human; Humans; Incidence; Inflammatory Bowel Diseases; Piperidines; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; United States | 2019 |
Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Databases, Factual; Female; Herpes Zoster; Humans; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome; Young Adult | 2014 |
Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis.
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Incidence; Male; Middle Aged; Piperidines; Proportional Hazards Models; Pyrimidines; Pyrroles; Risk Factors; Sex Factors | 2016 |
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Clinical Trials as Topic; Female; Herpes Zoster; Humans; Immunocompromised Host; Incidence; Infections; Male; Middle Aged; Neoplasms; Opportunistic Infections; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Time Factors; Tuberculosis; Young Adult | 2017 |
Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Comparative Effectiveness Research; Direct-to-Consumer Advertising; Herpes Zoster; Humans; Intestinal Perforation; Natural Language Processing; Piperidines; Pyrimidines; Pyrroles; Social Media | 2017 |
[Distamycin A in therapy of most severe types of herpes zoster].
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Herpes Zoster; Humans; Male; Pyrroles | 1969 |